GlassScriptPhysician profile
Patrick Finnan Vining
NPI 1063900249
$6,355.63
in general payments reported to CMS, 2019-2025
11 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2021: $24.46 · 2022: $3,595 · 2023: $762 · 2024: $1,462 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,829 · Travel and Lodging: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,828.69 |
| Travel and Lodging | $674.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,027.36 | 2022 | |
| Zimmer Biomet Holdings, INC. | $1,910.41 | 2022-2024 | Sternalock Blu System |
| Atricure, INC. | $1,447.43 | 2023-2025 | Synergy Ablation System |
| Body Vision Medical INC. | $229.35 | 2023 | Lungvision |
| Medtronic, INC. | $183.61 | 2024-2025 | Signia, Corevalve Evolut R |
| Davol INC. | $140.15 | 2023-2024 | Arista Ah Flexitip |
| Livanova USA, INC. | $132.81 | 2019 | |
| Kls-Martin L.P. | $99.96 | 2019 | |
| Genentech USA, INC. | $95.68 | 2023 | |
| Baxter Healthcare | $64.41 | 2024 | Perclot, Preveleak |
| Getinge USA Sales, LLC | $24.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Vining listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.